Avidity Biosciences Announces U.S. Managed Access Program for Investigational Therapy del-zota in DMD44 Life Science Investing
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 Life Science Investing
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company's Board of Directors Pharmaceutical Investing
PTC Expands Relationship with Garrett Motion to Transform New Product Development Life Science Investing
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th Life Science Investing
Harmony Biosciences Announces Initiation of First-In-Human Study With Potential Best-In-Class Orexin 2 Receptor Agonist for Central Disorders of Hypersomnolence Life Science Investing
Quantum-Si to Highlight Significant Proteus Platform Development Progress and Provide Insights into the Company's Industry Leading Technology Pipeline at Investor & Analyst Day Life Science Investing
Anavex Life Sciences to Present at the 44TH ANNUAL J.P. MORGAN Healthcare Conference Life Science Investing
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology Life Science Investing
Profound Medical Celebrates The Hong Center's 200th Independent TULSA Procedure for Prostate Disease Life Science Investing
